Development of a Quantitative Systems Pharmacology (QSP) Platform to Support Translational Research and Clinical Development in Immuno-Oncology

被引：0
|
作者：
Schmidt, Brian J. [1 ]
Bartlett, Derek W. [2 ]
Agrawal, Shruti [1 ]
Reed, Michael [2 ]
Jure-Kunkel, Maria [1 ]
Gutierrez, Andres A. [1 ]
Clynes, Raphael A. [1 ]
Fischer, Bruce S. [1 ]
Surywanshi, Satyendra [1 ]
Kadambi, Ananth [2 ]
Friedrich, Christina [2 ]
Kudrycki, Katherine [2 ]
Roy, Amit [1 ]
Leil, Tarek A. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] Rosa & Co, San Carlos, CA USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-27
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [21] Development and validation of a screening platform for the identification of novel immuno-oncology targets
    Scoumanne, Ariane
    Rabolli, Virginie
    Legrand, Lea
    Martini, Murielle
    Letellier, Marie-Claire
    Crosignani, Stefano
    Queva, Christophe
    Detheux, Michel
    Cauwenberghs, Sandra
    Swiercz, Jakub
    CANCER RESEARCH, 2017, 77
  • [22] Leveraging multi-omics data to empower quantitative systems pharmacology in immuno-oncology
    Arulraj, Theinmozhi
    Wang, Hanwen
    Ippolito, Alberto
    Zhang, Shuming
    Fertig, Elana J.
    Popel, Aleksander S.
    BRIEFINGS IN BIOINFORMATICS, 2024, 25 (03)
  • [23] Emulation of Quantitative Systems Pharmacology models to accelerate virtual population inference in immuno-oncology
    Pawlowski, Tomasz
    Bokota, Grzegorz
    Lazarou, Georgia
    Kierzek, Andrzej M.
    Sroka, Jacek
    METHODS, 2024, 223 : 118 - 126
  • [24] Immuno-oncology trends: preclinical models, biomarkers, and clinical development
    Franklin, Maryland Rosenfeld
    Platero, Suso
    Saini, Kamal S.
    Curigliano, Giuseppe
    Anderson, Steven
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [25] Immuno-Oncology companion diagnostics development: a complex systems approach
    Barrera, Lourdes
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [26] New patient derived lymphoma xenograft (PDX) panel for drug development, immuno-oncology and translational research
    Brzezicha, B.
    Becker, M.
    Stecklum, M.
    Conrad, T.
    Janz, M.
    Bittner, A.
    Schmitt, C. A.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S41 - S41
  • [27] Development and clinical validation of a quantitative mass spectrometric assay for immuno-oncology targets in FFPE samples
    Thyparambil, Sheeno P.
    Cecchi, Fabiola
    An, Eunkyung
    Liao, Wei-Li
    Burrows, Jon
    Hembrough, Todd
    Catenacci, Daniel
    CANCER RESEARCH, 2015, 75
  • [28] Development of a Quantitative Systems Pharmacology (QSP) Model of Psoriasis: Overview and Challenges
    Bansal, Loveleena
    Wilde, Tom
    Kang, Grace
    Baillie, Rebecca
    Friedrich, Christina
    Damian, Valeriu
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S103 - S104
  • [29] Facilitating translational research with interactive tools for immuno-oncology data
    Thorsson, Vesteinn
    Eddy, James A.
    Lamb, Andrew
    Gibbs, David L.
    Shmulevich, Ilya
    Guinney, Justin
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [30] Development and validation of a patient derived xenograft based preclinical platform for immuno-oncology drug development
    Oswald, E.
    Grote, A.
    Bug, D.
    Loehr, A.
    Lenhardt, D.
    Niedermann, G.
    Merhof, D.
    Feuerhake, F.
    Schueler, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S108 - S108
12345